CVOJMHFPBNLGOU-PBKJPEDESA-N
C32H35F2N7O4 — CID 121455618
Data last refreshed: (MolForge compound catalog, from PubChem)
About CVOJMHFPBNLGOU-PBKJPEDESA-N
CVOJMHFPBNLGOU-PBKJPEDESA-N (PubChem CID 121455618) has the molecular formula C32H35F2N7O4 and a molecular weight of 619.67 g/mol. Its IUPAC name is 4-[(2R,5S)-2-[8-amino-1-[4-[[4-(difluoromethyl)-2-pyridinyl]carbamoyl]phenyl]imidazo[1,5-a]pyrazin-3-yl]-5-methylmorpholin-4-yl]-1-methylcyclohexane-1-carboxylic acid.
Molecular Properties
| Compound Name | CVOJMHFPBNLGOU-PBKJPEDESA-N |
|---|---|
| PubChem CID | 121455618 |
| Molecular Formula | C32H35F2N7O4 |
| Molecular Weight | 619.67 g/mol |
| Exact Mass | 619.27 |
| IUPAC Name | 4-[(2R,5S)-2-[8-amino-1-[4-[[4-(difluoromethyl)-2-pyridinyl]carbamoyl]phenyl]imidazo[1,5-a]pyrazin-3-yl]-5-methylmorpholin-4-yl]-1-methylcyclohexane-1-carboxylic acid |
| SMILES | C[C@H]1CO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)F)ccn4)cc3)c3c(N)nccn23)CN1C1CCC(C)(C(=O)O)CC1 |
| InChI | InChI=1S/C32H35F2N7O4/c1-18-17-45-23(16-41(18)22-7-10-32(2,11-8-22)31(43)44)29-39-25(26-28(35)37-13-14-40(26)29)19-3-5-20(6-4-19)30(42)38-24-15-21(27(33)34)9-12-36-24/h3-6,9,12-15,18,22-23,27H,7-8,10-11,16-17H2,1-2H3,(H2,35,37)(H,43,44)(H,36,38,42)/t18-,22?,23+,32?/m0/s1 |
| InChIKey | CVOJMHFPBNLGOU-LYUGDNGYSA-N |
| XLogP | 5.36 |
| TPSA | 147.97 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 619.67 |
| LogP ≤ 5 | 5.36 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121455618 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.